GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » Common Stock

Vytrus Biotech (XMAD:VYT) Common Stock : €0.08 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vytrus Biotech Common Stock?

Vytrus Biotech's quarterly common stock stayed the same from Jun. 2023 (€0.07 Mil) to Dec. 2023 (€0.07 Mil) but then increased from Dec. 2023 (€0.07 Mil) to Jun. 2024 (€0.08 Mil).

Vytrus Biotech's annual common stock stayed the same from Dec. 2021 (€0.07 Mil) to Dec. 2022 (€0.07 Mil) and stayed the same from Dec. 2022 (€0.07 Mil) to Dec. 2023 (€0.07 Mil).


Vytrus Biotech Common Stock Historical Data

The historical data trend for Vytrus Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vytrus Biotech Common Stock Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 0.07 0.07 0.07 0.07 0.07

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.07 0.07 0.07 0.08

Vytrus Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Vytrus Biotech Business Description

Traded in Other Exchanges
N/A
Address
Sant Gaieta 121, 2nd, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.

Vytrus Biotech Headlines

No Headlines